• Product NameValdecoxib
• Brief DescriptionInhibitors
• Purification97.66%
• Biological ActivityValdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
• Target NameCOX inhibitor
• CAS No. 181695-72-7
• Calculated MW 314.36
• Formulation C16H14N2O3S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O
  Pathways:Immunology/Inflammation; Neuroscience
  Receptor:COX-2
  Boling pt:
  Melting pt:162-164C
  Solubility:Ethanol: 18 mg/mL (57.25 mM); DMSO: 63 mg/mL (200.4 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Talley JJ, et al. J Med Chem. 2000 Mar 9;43(5):775-7.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting